Covid-19: why Merck’s pill will not be able to replace vaccines – archyde

France has ordered enough to treat 50,000 patients with Molnupiravir, the pill against severe forms which has yet to be validated by the European Medicines Agency. But if this supplement to vaccination is eagerly awaited, it “is not a miracle cure”.